For: | Song H, Zhong LP, He J, Huang Y, Zhao YX. Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clin Cases 2019; 7(16): 2143-2154 [PMID: 31531310 DOI: 10.12998/wjcc.v7.i16.2143] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i16/2143.htm |
Number | Citing Articles |
1 |
Fang Huang, Chuanjing Dai, Youni Zhang, Yuqi Zhao, Yigang Wang, Guoqing Ru. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.889403
|
2 |
Mahalaxmi Iyer, Nandita Ravichandran, Panimalar Abirami Karuppusamy, Roselin Gnanarajan, Mukesh Kumar Yadav, Arul Narayanasamy, Balachandar Vellingiri. Immunology for Engineers. Advances in Protein Chemistry and Structural Biology 2024; 140: 419 doi: 10.1016/bs.apcsb.2023.12.007
|
3 |
Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali. Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 2020; 88: 106944 doi: 10.1016/j.intimp.2020.106944
|
4 |
Amina Nawal Bahoussi, Pir Tariq Shah, Jia-Qi Zhao, Pei-Hua Wang, Yan-Yan Guo, Changxin Wu, Li Xing. Multiple potential recombination events among Newcastle disease virus genomes in China between 1946 and 2020. Frontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1136855
|
5 |
Bei Ru Lee, Jeevanathan Kalyanasunandram, Kavitha Murulitharan, Kok Song Lai, Suet Lin Chia, Khatijah Yusoff. Reduced pathogenicity of velogenic NDV strain AF22420-I via site-directed mutagenesis of V gene. Asia Pacific Journal of Molecular Biology and Biotechnology 2021; : 59 doi: 10.35118/apjmbb.2021.029.3.08
|
6 |
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El-Deiry. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022; 14(4): 1028 doi: 10.3390/cancers14041028
|
7 |
RajLaxmi Sarangi, Sanjukta Mishra, Srikrushna Mahapatra. Cancer Vaccines: A Novel Revolutionized Approach to Cancer Therapy. Indian Journal of Clinical Biochemistry 2024; doi: 10.1007/s12291-024-01201-3
|
8 |
Esam Bashir Yahya, Amaal Mohammed Alqadhi. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sciences 2021; 269: 119087 doi: 10.1016/j.lfs.2021.119087
|
9 |
Aezam Rasekhi Kazeruni, Nahid Babaei, Hadi Esmaeili Gouvarchin Ghaleh, Abbas Doosti, Mahdieh Farzanehpour. Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13011-0
|
10 |
Seyed-Mahmood Seyed-Khorrami, Arezou Azadi, Nasrin Rastegarvand, Ala Habibian, Hoorieh Soleimanjahi, Marek J. Łos. A promising future in cancer immunotherapy: Oncolytic viruses. European Journal of Pharmacology 2023; 960: 176063 doi: 10.1016/j.ejphar.2023.176063
|
11 |
Volker Schirrmacher. New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection. Biomedicines 2020; 8(3): 55 doi: 10.3390/biomedicines8030055
|
12 |
Deok-Hwan Kim, Jiho Lee, Da-Ye Lee, Seung-Hun Lee, Jei-Hyun Jeong, Ji-Yun Kim, Jiwon Kim, Yang-Kyu Choi, Joong-Bok Lee, Seung-Young Park, In-Soo Choi, Sang-Won Lee, Sungsu Youk, Chang-Seon Song. Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection. Vaccines 2024; 12(8): 921 doi: 10.3390/vaccines12080921
|
13 |
Peter Anto Johnson, Alyssa Wu, John Christy Johnson, Zachary Schauer, Terrence Wu, Francis Fernandes, Reinette Schabert, Austin Mardon. Advances in DNA- and RNA-Based Oncolytic Viral Therapeutics and Immunotherapies. Applied Microbiology 2022; 2(2): 319 doi: 10.3390/applmicrobiol2020024
|
14 |
Mohamed A. Elbehairy, Siba K. Samal, George A. Belov. Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.
Journal of General Virology
2022; 103(6) doi: 10.1099/jgv.0.001761
|
15 |
Deok-Hwan Kim, Jiho Lee, Sungsu Youk, Jei-hyun Jeong, Da-ye Lee, Hyo-seon Ju, Ha-na Youn, Jin-cheol Kim, Soo-bin Park, Ji-eun Park, Ji-yun Kim, Tae-hyeon Kim, Seung-hun Lee, Hyukchae Lee, Lah Mouhamed Abdallah Amal Abdal, Dong-Hun Lee, Pil-Gu Park, Kee-Jong Hong, Chang-Seon Song. Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection. Vaccine 2023; 41(33): 4787 doi: 10.1016/j.vaccine.2023.05.071
|
16 |
Amir Sasan Mozaffari Nejad, Fatemeh Fotouhi, Parvaneh Mehrbod, Mohsen Keshavarz, Mohammad Yousef Alikhani, Amir Ghaemi. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways. Microbial Pathogenesis 2020; 147: 104438 doi: 10.1016/j.micpath.2020.104438
|
17 |
Ying Gao, Hui Ji, Lin Peng, Xiuge Gao, Shanxiang Jiang. Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine. Molecules 2020; 25(11): 2505 doi: 10.3390/molecules25112505
|
18 |
Carla Giles, Thiru Vanniasinkam. Viral Vectors in Veterinary Vaccine Development. 2021; : 21 doi: 10.1007/978-3-030-51927-8_3
|
19 |
Ziyang (Steve) Yin, Zhengfeng Wang. Strategies for engineering oncolytic viruses to enhance cancer immunotherapy. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1450203
|
20 |
Laura Enekegho, David Stuart. Smart Oncolytic Adenovirotherapy to Induce Killing of Cancer Cells and Elicit Antitumor Immunity. Eureka 2022; 7(1) doi: 10.29173/eureka28752
|
21 |
Guowei Tang, Damei Wu, Minghao Guo, Huashan Li. LncRNA MIR497HG inhibits colorectal cancer progression by the miR-3918/ACTG2 axis. Journal of Genetics 2022; 101(1) doi: 10.1007/s12041-022-01367-w
|
22 |
Sitanshu Sekhar Lahiri, Amlan Chakraborty. A holistic cure for cancer and survival from the indirect effects of nuclear attack. Advances in Biomedical and Health Sciences 2024; 3(3): 123 doi: 10.4103/abhs.abhs_17_24
|
23 |
Anne Everts, Melissa Bergeman, Grant McFadden, Vera Kemp. Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses. Biomedicines 2020; 8(11): 474 doi: 10.3390/biomedicines8110474
|
24 |
Zhihui Ruan, Jiangyang Chi, Yue Kong, Chengcheng Li, Xiaolan Ruan, Xing Zhou, Yanxi Chen, Yongkui Li, Zhen Luo. Natural Oncolysis of Enterovirus 71 in Antitumor Therapy of Colorectal Cancer. Advanced Biology 2023; 7(7) doi: 10.1002/adbi.202200336
|
25 |
Deeba Naz, Sajjad ur Rahman, Muhammad Aamir Aslam, Faqir Muhammad. Newcastle disease virus in poultry with an interface as a human vector. Veterinary Vaccine 2022; 1(1): 100003 doi: 10.1016/j.vetvac.2022.100003
|
26 |
Huiming Yang, Jiaxin Tian, Jing Zhao, Ye Zhao, Guozhong Zhang. The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy. Viruses 2024; 16(6): 886 doi: 10.3390/v16060886
|
27 |
Kousain Kousar, Faiza Naseer, Maisa Siddiq Abduh, Sadia Anjum, Tahir Ahmad. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1175535
|
28 |
Upasana Pathak, Ramprasad B. Pal, Nagesh Malik. The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus. Life 2023; 13(8): 1626 doi: 10.3390/life13081626
|
29 |
Li-Feng Hu, Huan-Rong Lan, Dong Huang, Xue-Min Li, Ke-Tao Jin. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.769305
|